• ScienceDaily | 9/11/2018 | Staff
    The team hope the compound -developed after 10 years of painstaking research will be trialled on humans within three to four years. The drug- which works by targeting Mycobacterium tuberculosis'...
    170 views moni
 
« Previous Articles1

Welcome to Long Room!

Where The World Finds Its News!